Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3013336	p-aminoh	— (—)	182	470	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Metabolic disorders

6.32

30.36

4.7

1.5

—

Intestinal infectious diseases

108

4.69

26.10

2.7

2.2

—

Care involving use of rehabilitation procedures

5.37

26.10

3.0

2.1

—

Intestinal stricture

16.18

24.54

3.3

3.7

—

Nausea and vomiting

5.73

23.38

3.0

1.9

—

Diarrhoea and gastroenteritis of presumed infectious origin

104

4.72

23.13

2.9

2.2

—

Other disorders of glucose regulation and pancreatic internal secretion

12.29

22.08

1.5

3.6

—

Endocrine, nutritional and metabolic diseases

4.63

19.98

2.8

1.7

—

Mental retardation, excluding more controls

8.36

19.74

1.6

3.3

—

Procreative management

4.63

18.81

3.1

2.5

—

Other disorders of fluid, electrolyte and acid-base balance

14.92

18.58

6.2

2.5

—

Disorders of other endocrine glands

100

4.43

18.38

3.0

2.4

—

Hypoglycaemia, other or unspecified

11.25

17.99

1.4

3.1

—

Symptoms and signs involving the nervous and musculoskeletal systems

4.66

17.90

1.9

2.1

—

Persons encountering health services for specific procedures and health care

109

3.58

16.74

2.5

2.3

—

Viral and other specified intestinal infections

5.21

16.24

4.2

2.1

—

Diseases of the digestive system

5.43

16.09

2.8

2.4

—

Motor disorders, excluding more controls

7.74

15.33

3.4

2.9

—

Speech and linguistic disorders, excluding more controls

6.32

15.32

1.5

3.5

—

Implicit Sepsis

5.08

15.05

3.6

1.8

—

Anxiety disorders, excluding more controls

6.41

14.94

2.4

3.6

—

Implicit viral Sepsis

8.02

14.88

4.9

2.2

—

Viral Sepsis

8.02

14.88

4.9

2.2

—

Psychiatric diseases

4.23

14.78

2.6

3.1

—

Any mental disorder

4.23

14.78

2.6

3.1

—

Other symptoms and signs involving the nervous and musculoskeletal systems

5.28

14.62

2.2

2.1

—

Malaise and fatigue

5.63

13.64

2.3

2.5

—

Specific developmental disorder of motor function

6.55

13.40

3.4

2.2

—

Disorders of psychological development

4.23

13.27

1.8

2.8

—

Mixed specific developmental disorders

5.51

13.16

2.8

—

Cerebral palsy and other paralytic syndromes

7.85

13.14

2.6

3.0

—

Delayed milestone in childhood

4.32

12.77

2.7

2.4

—

Medical observation and evaluation for suspected diseases and conditions

5.91

12.73

2.5

2.1

—

Other endocrine disorders

4.14

12.60

2.5

2.4

—

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

3.82

12.52

3.0

2.5

—

Implicit bacterial Sepsis

9.83

12.42

2.8

2.9

—

Other reaction to severe stress, and adjustment disorders

7.73

12.27

2.4

3.7

—

Lack of expected normal physiological development

5.14

11.98

3.2

1.9

—

Diseases of the myoneural junction and muscle

10.86

11.96

2.5

3.0

—

Explicit Sepsis

4.71

11.85

3.1

2.2

—

Disorders of ocular muscles, binocular movement, accommodation and refraction

115

3.45

11.74

1.8

2.9

—

Exclusions for E4_PCOS_BROAD

4.65

11.38

3.9

2.3

—

Condition for Implicit Sepsis (Organ dysfunction codes)

3.98

11.13

3.6

1.9

—

Short stature, not elsewhere classified

4.08

11.09

2.5

2.2

—

Hypopituitarism

7.31

10.98

5.7

2.7

—

Anaemias

4.60

10.88

3.4

2.3

—

Mental retardation

4.46

10.73

1.6

2.6

—

Mental retardation, wide definition

4.46

10.73

1.6

2.6

—

Epilepsy

3.67

10.33

2.6

2.4

—

All influenza

5.13

10.29

6.2

1.8

—

General examination and investigation of persons without complaint and reported diagnosis

5.32

10.29

2.5

2.1

—

Neurotic, stress-related and somatoform disorders

3.78

10.05

2.2

2.9

—

Speech and linguistic disorders

3.63

10.03

1.5

3.1

—

Anxiety disorders

3.77

10.00

2.2

2.9

—

Other septicaemia

4.80

9.96

3.4

2.4

—

Persons encountering health services in circumstances related to reproduction

104

3.00

9.79

3.2

2.3

—

Specific development disorders of scholastic skills

6.05

9.78

1.4

3.6

—

Other problems related to primary support group, including family circumstances

3.57

9.54

3.2

2.6

—

Bacterial Sepsis

6.05

9.45

2.8

2.3

—

Disorders of ornithine metabolism

+∞

9.44

7.8

0.0

—

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

4.88

9.29

4.8

2.4

—

Motor disorders

4.51

9.10

3.4

1.9

—

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

3.22

9.10

2.3

2.5

—

Other functional intestinal disorders

3.31

9.06

2.4

1.9

—

Convulsions, not elsewhere classified

4.21

8.93

1.6

2.5

—

Congenital malformations of the nervous system

7.32

8.86

1.8

4.0

—

Hyperkinetic disorders, excluding more controls

5.35

8.63

2.6

3.4

—

Septicaemia

3.98

8.61

3.3

2.4

—

Congenital malformations, deformations and chromosomal abnormalities

3.19

8.59

2.7

2.3

—

GASTRO-related operations

2.96

8.16

3.3

2.0

—

Any gastric operation

2.96

8.16

3.3

2.0

—

Other disorders starting during childhood or adolecense, excluding more controls

4.61

8.15

3.9

3.1

—

Complications of medical and surgical care

4.15

7.94

4.2

1.8

—

Aplastic and other anaemias

4.89

7.79

4.2

2.4

—

All anxiety disorders

3.94

7.74

2.6

2.7

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

120

2.61

7.71

3.1

2.5

—

Paralytic ileus and intestinal obstruction

15.00

7.70

2.6

3.5

—

Transplanted organ and tissue status

5.02

7.65

3.7

2.0

—

Complications of surgical and medical care, not elsewhere classified

3.66

7.64

3.7

2.1

—

Cerebral palsy

6.77

7.63

2.5

2.9

—

Nutritional anaemias

4.30

7.56

2.9

3.2

—

Disorders of refraction and accommodation

3.21

7.45

2.0

2.9

—

Other respiratory disorders and diseases

6.32

7.24

3.5

1.7

—

Other diseases of the respiratory system

6.32

7.24

3.5

1.7

—

Somatoform disorder

15.74

7.22

1.7

4.1

—

Other and unspecified anaemias

5.01

7.10

4.5

2.5

—

Iron deficiency anaemia

4.25

7.09

2.8

3.3

—

Other anaemias

4.99

7.08

4.5

2.5

—

Exclusions for E4_PCOS_CONSORTIUM

2.89

6.93

4.0

2.5

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

104

2.52

6.93

2.6

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

3.18

6.93

1.6

2.8

—

Substance abuse, excluding more controls

7.96

6.90

2.9

3.5

—

Other anxiety disorders

4.20

6.78

2.4

3.0

—

Other or unspecified ileus, impaction or obstruction

16.68

6.73

2.9

4.2

—

Fever of other and unknown origin

3.44

6.71

3.1

2.4

—

Dentofacial anomalies [including malocclusion]

3.35

6.55

2.0

2.7

—

Complications of procedures, not elsewhere classified

4.09

6.52

4.1

2.3

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

114

2.52

6.41

2.9

2.5

—

Other noninfective gastroenteritis and colitis

3.29

6.39

3.2

2.2

—

Specific development disorders of speech and language

3.75

6.31

1.5

3.1

—

All influenza (not pneumonia)

5.46

6.28

7.8

1.8

—

Chronic kidney disease

4.98

6.17

5.3

2.7

—

Renal failure

4.42

6.08

4.9

2.5

—

Anxiety (asthma-related co-morbidities)

3.30

6.05

2.6

2.4

—

Examination and observation for other reasons

4.21

5.98

2.6

2.1

—

Emotional disorders starting during childhood or adolecense, excluding more controls

5.69

5.94

1.4

3.7

—

Hypokalaemia

15.02

5.90

2.9

2.8

—

Wide developmental disorders, excluding more controls

4.80

5.89

1.8

3.1

—

Influenza and pneumonia

129

2.29

5.84

4.0

2.2

—

Other and unspecified mental retardation

3.86

5.84

1.1

2.6

—

Astigmatism

4.39

5.75

1.3

3.3

—

Noninfectious colitis NAS

5.01

5.74

2.7

3.6

—

Persons encountering health services in other circumstances, wide

104

2.30

5.62

2.4

2.6

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

4.04

5.58

4.2

1.8

—

Other metabolic disorders

12.87

5.57

1.9

2.4

—

Mood disorders, excluding more controls

4.14

5.55

3.2

3.5

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

4.24

5.54

4.2

2.5

—

Bacterial infection, other or unspecified

3.90

5.54

2.3

2.1

—

Dialysis, with operation codes

4.81

5.49

8.5

2.2

—

Pain, not elsewhere classified

4.80

5.49

1.9

2.6

—

Visual disturbances and blindness

3.14

5.45

1.5

2.4

—

Other diseases of the digestive system

4.62

5.25

2.8

—

GI-bleeding

4.62

5.25

2.8

—

Disorders of aromatic amino-acid metabolism

+∞

5.24

14.4

0.0

—

Neurological diseases

2.26

5.18

2.5

—

L04AA Selective immunosuppressants

4.00

5.16

3.7

2.3

—

L04AD Calcineurin inhibitors

3.76

5.08

3.9

2.3

—

Emotional disorders and disorders of social functioning with onset specific to childhood

3.96

5.06

1.4

2.7

—

Pervasive developmental disorders excl. Autism + Asperger

4.52

5.03

1.8

3.2

—

Other diseases of intestines

129

2.12

4.97

2.8

2.5

—

Other and unspecified iron deficiency

4.06

4.88

2.4

3.5

—

Factors influencing health status and contact with health services

7.53

4.83

4.7

1.1

—

Hypertension, essential

4.44

4.83

3.7

2.1

—

Headache

2.98

4.82

2.0

2.5

—

Myalgia

9.01

4.78

1.3

2.8

—

ILD medications: immunosuppressive drugs

2.64

4.77

2.9

2.6

—

Deposits [accretions] on teeth

2.98

4.75

3.2

2.6

—

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

2.85

4.64

3.7

2.4

—

Other medical care

4.48

4.61

1.2

2.5

—

Diagnoses used for exclusion with ILD

14.01

4.57

5.4

3.0

—

Inflammatory diseases of the central nervous system

8.20

4.56

3.0

4.8

—

Abnormalities of gait and mobility

4.77

4.53

1.1

1.4

—

Intestinal malabsorption

10.04

4.52

3.8

4.8

—

Other special examinations and investigations of persons without complaint or reported diagnosis

3.50

4.50

3.6

2.1

—

Renal tubulo-interstitial diseases

2.47

4.48

3.5

2.1

—

Abnormal findings on examination of blood, without diagnosis

3.64

4.48

4.2

2.6

—

Hypothyroidism (congenital or acquired)

4.40

4.45

4.4

2.8

—

Infections, IBD-co-morbidities

5.21

4.45

3.9

2.6

—

General symptoms and signs

2.40

4.44

2.8

2.4

—

Persons encountering health services for examination and investigation

3.47

4.43

3.6

2.1

—

Other diseases of pleura

4.09

4.40

1.9

2.9

—

Artificial opening status

7.53

4.35

2.3

2.2

—

Gastro-oesophageal reflux disease

3.14

4.33

3.4

2.0

—

Dental caries

2.79

4.29

3.9

2.7

—

Fungal Sepsis

11.72

4.28

2.3

2.8

—

Acute tubulo-interstitial nephritis

2.82

4.26

3.7

2.3

—

Childhood asthma (age<16)

3.40

4.19

1.9

2.4

—

Childhood asthma (age<16), excluding more controls

3.40

4.19

1.9

2.4

—

Focal epilepsy, strict definition

3.26

4.18

1.4

3.2

—

Certain infectious and parasitic diseases

2.23

4.16

2.4

2.3

—

Other congenital malformations of the digestive system

2.90

4.12

2.1

2.7

—

Hypothyroidism, other/unspecified

2.87

4.09

3.6

2.9

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

2.87

4.08

3.6

2.9

—

Abnormal involuntary movements

8.01

4.06

1.0

2.3

—

Irregular menses

3.89

4.04

2.9

2.6

—

Symptoms and signs concerning food and fluid intake

3.93

3.97

2.3

3.1

—

Visual disturbances

3.02

3.95

1.6

2.4

—

Episodal and paroxysmal disorders

120

1.96

3.95

2.2

2.4

—

Other and unspecified tonsillitis

2.69

3.91

3.7

2.1

—

Any reimbursement code in KELA

2.42

3.87

3.9

1.1

—

Benzodiazepine use

2.67

3.87

3.2

2.9

—

Noninfective enteritis and colitis

100

2.40

3.86

3.1

2.3

—

KRA_PSY_EATING, excluding more controls

7.26

3.85

1.5

2.5

—

ILD medications: prednisolone, methylprednisolone, prednisone

2.19

3.84

2.7

2.9

—

Mild mental retardation

6.04

3.82

1.4

3.7

—

Other congenital malformations of brain

9.05

3.80

2.1

4.8

—

Coagulation defects, purpura and other haemorrhagic conditions

3.80

3.6

2.3

—

Other congenital malformations of intestine

8.91

3.79

3.4

3.5

—

Nystagmus and other irregular eye movements

8.85

3.78

1.4

3.8

—

Other bacterial intestinal infections

8.76

3.77

2.1

3.8

—

Adrenocortical insufficiency

12.05

3.76

2.3

5.0

—

Cerebral cysts

12.03

3.76

2.0

3.0

—

Misadventures to patients during surgical and medical care

12.01

3.76

6.5

1.0

—

Other diseases of intestine

12.01

3.76

2.7

5.0

—

Personality disorders, excluding more controls

12.00

3.76

1.0

4.2

—

Respiratory insufficiency

11.99

3.76

1.7

2.0

—

All pneumoniae

136

1.98

3.69

3.9

2.3

—

Focal epilepsy

3.00

3.68

1.4

3.0

—

Anomalies of dental arch relationship, including avohilmo

2.52

3.67

2.2

—

Nephropathy related operations

3.67

3.63

9.2

2.5

—

Covid-19 confirmed case

3.43

3.61

3.1

2.9

—

Emotional disorders starting during childhood or adolescence

3.41

3.57

1.3

2.4

—

Other disorders starting during childhood or adolescence

2.46

3.57

3.7

2.6

—

Volume depletion

7.79

3.55

2.4

2.3

—

Pain and other conditions associated with female genital organs and menstrual cycle

6.40

3.55

2.6

2.9

—

Dizziness and giddiness

3.16

3.54

1.1

2.8

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

3.09

3.54

3.8

1.8

—

Other strabismus

2.50

3.51

2.1

2.5

—

Non-selective monoamine reuptake inhibitors

9.70

3.43

3.2

1.3

—

Oxycodone

9.67

3.42

2.5

1.3

—

ILD medications

110

1.95

3.37

2.6

—

Hypothyroidism, levothyroxine purchases

3.96

3.37

4.7

2.9

—

Hypothyroidism and >3 levothyroxin purchases

3.96

3.37

4.7

2.9

—

Symptoms and signs involving speech and voice

5.00

3.36

2.4

3.1

—

Extrapyramidal and movement disorders

5.00

3.36

1.1

3.8

—

Haemolytic anaemias

7.03

3.36

3.3

—

Other disorders of adrenal gland

7.02

3.36

2.1

4.5

—

Bacterial intestinal infections, IBD co-morbidities

7.00

3.36

2.1

3.5

—

Disorders of speech understanding and production

2.85

3.35

1.6

2.9

—

Bleeding

2.39

3.32

3.0

2.3

—

Osteopathies and chondropathies

2.95

3.31

1.6

2.8

—

Pneumonia, organism unspecified

119

2.01

3.31

3.1

2.0

—

Symptoms and signs involving the digestive system and abdomen

104

1.93

3.30

2.9

2.2

—

Codes for special purposes

2.54

3.28

2.8

2.5

—

Provisional assignment of new diseases of uncertain etiology

2.54

3.28

2.8

2.5

—

Crossbite

2.49

3.28

3.3

2.4

—

Congenital malformations of the musculoskeletal system, not elsewhere classified

8.65

3.27

3.7

—

Iron deficiency anaemia secondary to blood loss (chronic)

8.58

3.26

3.5

5.1

—

Abnormalities of breathing

105

1.98

3.25

2.2

2.9

—

Dental caries 2 and operation codes

111

2.08

3.24

2.7

2.8

—

Strabismus

2.33

3.22

2.0

2.4

—

Abnormal serum enzyme levels

4.68

3.19

5.3

1.9

—

Substance use, excluding alcohol

6.37

3.18

2.4

5.7

—

Constipation

110

2.02

3.16

2.8

2.0

—

Dyspnoea

2.37

3.15

2.6

2.2

—

Other diseases of hard tissues of teeth

2.15

3.15

2.7

—

Behavioural syndromes associated with physiological disturbances and physical factors

2.73

3.14

1.4

2.8

—

Diseases of oesophagus, stomach and duodenum

2.23

3.14

3.7

2.1

—

Mycoses

4.50

3.11

4.4

2.4

—

Other neurological diseases

2.89

3.08

2.9

2.3

—

2.24

3.08

3.7

2.3

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

2.24

3.08

3.7

2.3

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

134

1.89

3.05

3.0

2.5

—

Acute renal failure

7.50

3.05

4.7

2.6

—

Pneumonias (Asthma/COPD co-morbidities)

137

1.87

3.05

3.0

2.5

—

Disorders of the thyroid gland

2.37

3.05

3.5

2.8

—

Disorders of adult personality and behaviour

5.00

3.05

1.1

4.2

—

Erosion of teeth, including avohilmo

3.45

3.02

2.8

3.8

—

Viral pneumonia

4.29

2.99

7.3

1.9

—

Other disorders of eye and adnexa

4.29

2.99

1.4

3.4

—

Implicit fungal Sepsis

10.03

2.98

1.0

3.0

—

Other coagulation defects

10.01

2.98

1.4

3.0

—

Lung diseases due to external agents

10.01

2.98

3.4

6.8

—

Certain conditions originating in the perinatal period

2.22

2.97

2.5

2.8

—

Wide developmental disorders

2.84

2.92

1.8

2.7

—

Type of accident

3.34

2.90

2.4

2.7

—

Kidney transplant status

4.11

2.88

4.8

2.4

—

Erosion of teeth

5.43

2.87

2.4

2.2

—

Care involving dialysis

5.39

2.87

6.9

1.4

—

Nonorganic sleeping disorders, excluding more controls

5.39

2.86

1.3

2.6

—

Dental caries 2

116

1.96

2.84

2.7

—

Substance abuse

3.30

2.82

2.9

3.0

—

Other symptoms and signs involving cognitive functions and awareness

4.02

2.81

2.6

3.4

—

Depression or dysthymia

3.20

2.79

5.0

3.3

—

Abnormal weight loss

4.45

2.79

2.3

3.6

—

Other bacterial diseases

2.00

2.79

3.3

2.6

—

Viral infections characterized by skin and mucous membrane lesions

2.22

2.78

2.7

2.8

—

Other viral diseases

110

2.09

2.75

3.3

2.6

—

Encephalitis

8.36

2.75

2.6

4.3

—

Other complications of surgical and medical care, not elsewhere classified

8.34

2.75

2.2

3.0

—

Dependence on enabling machines and devices, not elsewhere classified

5.04

2.73

2.1

1.4

—

Visual impairment including blindness (binocular or monocular)

5.01

2.73

1.7

3.4

—

Dysphagia

5.00

2.72

3.0

1.1

—

Extracorporeal dialysis

6.01

2.70

7.0

1.4

—

Specific personality disorders

6.00

2.69

1.0

5.1

—

Persons encountering health services in other circumstances

2.50

2.69

2.5

2.3

—

Eating disorder

4.21

2.67

1.5

3.1

—

Mental and behavioural disorders due to psychoactive substance use

3.15

2.63

2.9

3.0

—

Acute suppurative otitis media

2.17

2.62

3.3

2.1

—

Other menopausal disorders

6.92

2.61

2.7

2.0

—

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

2.81

2.59

4.0

3.0

—

Candidiasis

4.67

2.59

2.3

2.6

—

Cardiomyopathy

4.67

2.59

1.3

2.1

—

Hypothyroidism, strict autoimmune

2.78

2.57

1.8

2.0

—

Follow-up examination after treatment for conditions other than malignant neoplasms

4.37

2.57

1.6

3.2

—

Weight loss

4.01

2.56

2.3

3.4

—

Eating disorders

4.00

2.56

1.5

3.5

—

Other viral diseases, not elsewhere classified

2.18

2.55

2.6

2.3

—

Disorders of mineral metabolism

7.15

2.55

11.0

2.7

—

Collagenous colitis

7.15

2.55

4.4

5.3

—

Cardiomyopathy (excluding other)

7.15

2.55

1.2

2.9

—

Colectomy operation

7.15

2.55

2.2

5.1

—

Undetermined asthma

7.14

2.54

1.2

1.1

—

Undetermined asthma, excluding more controls

7.14

2.54

1.2

1.1

—

Autism

5.48

2.54

1.0

4.6

—

Polycystic ovarian syndrome, consortium definition

2.80

2.54

2.8

2.7

—

Disturbance of activity and attention

2.43

2.54

2.8

2.7

—

Temporomandibular joint disorders

5.46

2.54

1.0

2.5

—

Cough

2.13

2.53

2.0

2.8

—

Retention of urine

5.64

2.52

1.0

2.3

—

Acute upper respiratory infections of multiple and unspecified sites

2.09

2.52

3.1

2.4

—

Noninflammatory disorders of female genital tract

3.02

2.49

2.8

2.3

—

Phobic anxiety disorders

4.38

2.47

1.6

2.9

—

Neurological diseases, wide definition

2.01

2.46

3.3

2.4

—

Asthma (mode)

2.27

2.45

1.7

2.3

—

Irritable bowel syndrome

5.00

2.40

3.7

3.6

—

Otitis media, unspecified

2.18

2.40

2.9

2.1

—

Depression medications

3.77

2.39

5.1

3.5

—

Concussion

2.14

2.38

2.6

2.3

—

Birth asphyxia

4.23

2.38

1.0

2.2

—

Event of undetermined intent

6.26

2.37

1.8

6.1

—

Cardiomyopathies, Primary/intrinsic

6.25

2.37

1.2

2.6

—

Hernia of abdominal wall, postoperative

6.25

2.37

2.6

1.3

—

Other spirochaetal diseases

4.12

2.36

1.4

3.6

—

Asthma

2.22

2.32

1.7

2.3

—

Diseases of the eye and adnexa

1.80

2.30

2.4

—

Asthma, excluding more controls

2.20

2.29

1.7

2.3

—

Digestive system disorders of fetus and newborn

6.14

2.28

4.4

1.2

—

Immunodeficiencies

4.63

2.27

1.7

4.3

—

Personality disorders

4.62

2.27

1.0

4.8

—

Disorders of optic nerve and visual pathways

3.89

2.25

7.9

3.5

—

Systemic connective tissue disorders

3.89

2.25

1.6

3.5

—

Nonsuppurative otitis media

2.08

2.24

2.6

2.0

—

Presence of other functional implants

4.13

2.24

5.7

1.1

—

Disorders of choroid and retina

2.76

2.23

4.8

3.0

—

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

5.56

2.21

1.6

1.3

—

Disorders of continuity of bone

5.56

2.21

1.4

5.7

—

Ptosis of eyelid

5.56

2.21

1.6

4.4

—

Open wound of ankle and foot

5.56

2.21

3.0

2.3

—

Unspecified privation

5.56

2.21

1.2

4.3

—

Polyuria

5.56

2.21

1.2

2.1

—

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

2.33

2.20

1.4

2.8

—

Supplementary factors related to causes of morbidity and mortality classified elsewhere

2.78

2.20

2.4

2.8

—

Suppurative and unspecified otitis media

2.02

2.19

3.0

2.1

—

Disorders of skin appendages

2.41

2.19

5.2

2.2

—

Asthma (only as main-diagnosis)

2.23

2.19

1.8

2.3

—

Excessive, frequent and irregular menstruation

3.34

2.19

3.4

2.5

—

Symptoms and signs involving the urinary system

2.11

2.16

3.4

2.4

—

Abnormal results of function studies

4.29

2.15

1.5

2.2

—

Schizophrenia or delusion

3.69

2.15

1.7

4.2

—

Schizophrenia, schizotypal and delusional disorders

3.69

2.15

1.7

4.2

—

Opioids

2.39

2.14

3.3

3.0

—

Use of hypnotics and sedatives

2.02

2.13

2.5

2.8

—

Asthma (only as main-diagnosis), excluding more controls

2.20

2.12

1.8

2.3

—

Other and unspecified disorders of psychological development

3.66

2.12

1.0

2.2

—

Hyperkinetic disorders

2.10

2.11

2.6

2.9

—

Hypermetropia

2.71

2.10

1.3

3.2

—

Disorders of conjunctiva

139

1.75

2.08

2.3

2.7

—

Syncope and collapse

3.22

2.07

1.6

3.1

—

First line medication for Crohn's disease

113

1.69

2.07

2.7

—

Contraceptive management

3.31

2.06

3.3

2.1

—

Myopia

3.50

2.05

3.7

4.2

—

Dental operations

2.05

3.6

1.8

—

Rash and other nonspecific skin eruption

4.00

2.04

1.2

3.3

—

Dermatitis and eczema

128

1.69

2.03

2.5

2.4

—

Oral corticosteroids

2.05

2.03

2.5

3.1

—

Bacterial pneumonia (organism specified)

2.68

2.03

1.3

2.6

—

Dentinal caries

2.31

2.02

4.3

3.0

—

Diseases of pulp and periapical tissues

3.08

2.01

1.6

2.5

—

Disorders of gallbladder, biliary tract and pancreas

2.25

2.01

2.0

2.8

—

Other disorders of urethra and urinary system

2.28

2.00

3.4

2.4

—

Bacterial pneumoniae

2.85

1.99

1.3

2.1

—

Crowding of teeth, including avohilmo

2.07

1.98

2.1

2.8

—

Osteoporosis

3.81

1.95

2.0

3.5

—

Shoulder lesions

2.90

1.93

9.1

2.4

—

Poisoning by drugs, medicaments and biological substances

3.75

1.93

2.5

3.8

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

2.58

1.92

1.4

2.5

—

Bacterial pneumonia, not elsewhere classified

2.95

1.89

1.4

1.8

—

Inflammatory bowel disease treatment related agents

100

1.70

1.87

2.1

3.0

—

Allergic conjunctivitis

2.15

1.87

1.4

3.1

—

Scissor bite

2.65

1.86

1.4

3.5

—

Other disorders of optic [2nd] nerve and visual pathways

3.54

1.83

9.0

3.6

—

Lyme disease

3.53

1.83

1.0

3.6

—

Conjunctivitis

138

1.70

1.83

1.6

2.7

—

Fitting and adjustment of other devices

4.23

1.82

1.6

2.7

—

Acute upper respiratory infections

1.82

3.1

2.4

—

Corneal ulcer

4.17

1.82

1.4

4.5

—

Other extrapyramidal and movement disorders in other diseases

4.17

1.82

1.2

5.2

—

Sequelae of external causes of morbidity and mortality

4.17

1.82

4.0

3.6

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

4.17

1.82

1.2

3.1

—

Deep bite

2.03

1.82

2.8

3.2

—

Used for control exclusion in common control thyroid runs

113

1.62

1.81

2.9

2.3

—

Dental caries 2, only avohilmo

113

1.74

1.80

3.0

2.8

—

Heterophoria

3.05

1.80

3.9

3.2

—

Disorders of tooth development and eruption

2.19

1.79

2.6

2.7

—

Amblyopia ex anopsia

2.77

1.79

1.3

3.0

—

Hypertension

1.95

1.79

3.6

1.9

—

Sleep disorders

2.76

1.79

1.3

3.0

—

Diseases of arteries, arterioles and capillaries

2.84

1.78

1.4

3.2

—

Other disorders of eyelid

3.41

1.77

1.5

3.1

—

Congenital malformations and deformations of the musculoskeletal system

1.95

1.77

2.1

2.7

—

Other retinal disorders

2.79

1.77

5.5

2.9

—

Asthma and allergy

2.73

1.76

1.8

2.3

—

Bronchitis

1.77

1.75

3.6

2.3

—

Congenital malformations of genital organs

2.16

1.75

5.3

2.3

—

Gastrointestinal diseases

1.73

1.75

3.1

2.2

—

Other eating disorders

3.34

1.74

1.7

3.2

—

Hyperkinetic disorders (excl. ADHD)

3.32

1.73

1.0

2.7

—

COPD/asthma/ILD related infections

1.79

1.73

3.6

2.3

—

COPD/asthma related infections

1.79

1.73

3.6

2.3

—

Other disorders originating in the perinatal period

2.33

1.72

1.6

2.2

—

Certain disorders involving the immune mechanism

2.92

1.72

1.6

3.2

—

Deforming dorsopathies

2.92

1.72

1.1

2.3

—

Other headache syndromes

2.92

1.72

2.0

1.9

—

Embedded teeth, including avohilmo

3.85

1.71

1.2

3.6

—

Other and unspecified nonorganic psychotic disorders

3.85

1.71

1.2

5.0

—

Voice disturbances

3.85

1.71

3.0

2.8

—

Abnormal findings on diagnostic imaging of lung

3.25

1.70

3.5

1.8

—

Autoimmune diseases related-to ILD

1.95

1.66

2.1

2.2

—

Haemorrhage from respiratory passages

2.82

1.65

1.0

1.9

—

Invasive ventilation

2.80

1.65

2.7

2.8

—

Hypertensive diseases

1.89

1.64

3.6

1.9

—

Artificial joint operation, meniscal resection

2.66

1.63

2.6

3.4

—

Direct fill therapy

2.25

1.63

4.1

2.3

—

Asthma and allergy, excluding more controls

2.55

1.63

1.8

2.3

—

Migraine without aura and triptan purchases

3.57

1.61

1.0

4.6

—

Other systemic involvement of connective tissue

3.57

1.61

1.8

4.2

—

Rotator cuff syndrome

3.18

1.61

6.3

1.7

—

Mouth breathing

1.84

1.60

1.5

2.9

—

Secondary hypertension

3.54

1.60

6.8

1.4

—

Other arrhythmias

2.28

1.60

3.0

2.2

—

Diseases of middle ear and mastoid

104

1.73

1.59

3.8

2.1

—

Fall on and from stairs and steps

3.00

1.58

2.5

3.3

—

Keratitis

2.69

1.58

1.3

3.4

—

Intracranial trauma

1.82

1.58

2.6

2.3

—

Migraine

1.96

1.57

2.5

2.8

—

Acute laryngitis and tracheitis

2.21

1.57

5.5

2.5

—

Atopic dermatitis, strict definition with reimbursement

110

1.76

1.57

2.5

2.4

—

Recurrent or chronic depression

3.10

1.56

6.5

2.8

—

121

1.72

1.53

1.9

2.9

—

Atopic dermatitis, strict definition

127

1.70

1.53

2.3

2.8

—

Fetus and newborn affected by maternal complications of pregnancy

0.00

1.53

0.0

2.2

—

Scoliosis

3.34

1.52

1.0

2.9

—

Insomnia

3.33

1.52

1.2

3.8

—

Other disorders of lacrimal gland

3.33

1.52

1.4

3.9

—

Fracture of foot, except ankle

2.59

1.51

4.3

2.8

—

Disorders of lacrimal system

2.86

1.50

1.3

3.3

—

Conjunctivitis (acute, non atopic)

1.82

1.49

2.3

2.4

—

Other congenital malformations

2.00

1.48

1.5

2.7

—

Other disorders of skin and subcutaneous tissue

2.23

1.45

3.2

2.2

—

Nonorganic sleeping disorders

2.50

1.45

1.3

3.0

—

Other antidepressants

2.03

1.45

3.2

2.8

—

Suicide or other Intentional self-harm

3.13

1.44

1.2

4.1

—

Asthma-related pneumonia

2.11

1.43

2.3

2.7

—

Asthma-related pneumonia or sepsis

2.11

1.43

2.3

2.7

—

Asthma, hospital admissions 3, pneumonia

2.11

1.43

2.3

2.7

—

Unspecified acute lower respiratory infection

2.73

1.43

5.7

3.2

—

Speech therapy

2.73

1.43

1.5

3.2

—

Personal history of other diseases and conditions

1.91

1.42

4.0

2.7

—

Ischaemic heart disease, wide definition

2.58

1.41

5.7

1.8

—

Diseases of the respiratory system

1.91

1.41

3.8

2.4

—

Cardiovascular diseases

122

1.52

1.40

2.7

—

Endometriosis

3.31

1.40

4.6

2.9

—

Other and unspecified dermatitis

2.17

1.39

7.4

2.8

—

Urticaria and erythema

1.85

1.39

5.2

2.4

—

Acute pharyngitis

2.16

1.37

2.2

2.7

—

Other disorders of gingiva or/and edentulous alveolar ridge

2.61

1.36

1.8

2.5

—

Malnutrition

2.95

1.36

2.4

2.5

—

Varicella [chickenpox]

2.95

1.36

2.6

3.9

—

Other acute lower respiratory infections

121

1.66

1.36

2.9

2.4

—

L04AX Other immunosuppressants

1.83

1.35

1.5

3.1

—

Oedema, not elsewhere classified

2.93

1.35

3.0

2.9

—

Non-invasive ventilation

2.94

1.34

6.2

2.2

—

1.76

1.32

2.6

2.1

—

Dermatitis

1.97

1.32

6.3

2.6

—

1.62

1.31

3.6

2.3

—

Mood [affective] disorders

1.77

1.30

3.2

2.6

—

Purpura and other haemorrhagic conditions

2.50

1.30

5.5

2.5

—

Leisure time condition

2.50

1.30

1.2

3.0

—

Genitourinary diseases

110

1.50

1.30

2.8

2.6

—

Mood disorders

1.77

1.30

3.2

2.6

—

Disorders of sclera, cornea, iris and ciliary body

2.09

1.30

1.3

3.0

—

Hypertensive diseases (excluding secondary)

1.82

1.30

4.1

1.8

—

Symptoms and signs involving the circulatory and respiratory systems

106

1.51

1.30

3.0

2.9

—

Convergent concomitant strabismus

2.78

1.28

1.0

3.9

—

Allergic asthma (mode)

2.31

1.27

1.8

2.3

—

Undescended testicle

2.30

1.27

7.6

2.4

—

Meniscus derangement

2.85

1.25

3.6

3.4

—

Allergic asthma (mode), excluding more controls

2.24

1.25

1.8

2.3

—

Contact with and exposure to communicable diseases

116

0.43

1.24

3.0

2.8

—

ILD medications: azathioprine

2.40

1.24

1.3

2.4

—

Allergic colitis

2.23

1.24

3.5

2.0

—

Focal epilepsy, mode (most common among epilepsy diagnosis)

2.00

1.23

1.1

3.0

—

Asthma-related infections

129

1.60

1.22

1.9

2.9

—

Asthma, hospital admission 2, infections

129

1.60

1.22

1.9

2.9

—

Subjective visual disturbances

2.63

1.21

1.8

3.6

—

Migraine without aura

2.16

1.21

2.1

2.3

—

Temporomandibular joint disorders, including avohilmo

2.16

1.21

2.0

3.4

—

Viral warts

2.50

1.15

1.2

3.4

—

Ulcerative colitis

2.50

1.15

1.6

3.8

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

2.50

1.15

1.2

3.5

—

Diseases of liver

2.50

1.15

2.2

3.5

—

Chronic sinusitis

2.50

1.15

5.0

2.8

—

Second line medication for Crohn's disease

1.72

1.14

1.5

3.1

—

Other/unspecified dorsalgia

2.49

1.14

2.4

2.7

—

Cholecystectomy

2.38

1.13

2.7

3.2

—

Hernia of abdominal wall

2.33

1.12

2.1

3.1

—

Coeliac disease

2.26

1.10

1.4

3.4

—

Cardiac murmurs and other cardiac sounds

1.83

1.09

1.3

2.8

—

Melanocytic naevi

2.38

1.09

2.6

2.3

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

1.92

1.09

1.7

2.9

—

Intermittent heterotropia

1.95

1.08

2.8

2.7

—

Codeine

2.04

1.08

1.3

3.0

—

Diseases of the ear and mastoid process

100

1.47

1.06

3.5

2.0

—

Tonsillectomy and adenotomy

134

1.46

1.05

2.0

2.4

—

Non-allergic asthma (mode)

2.10

1.04

1.6

2.2

—

Non-allergic asthma (mode), excluding more controls

2.10

1.04

1.6

2.2

—

Tooth eruption problems

1.85

1.04

1.4

3.6

—

Vasomotor and allergic rhinitis

104

1.61

1.03

2.1

2.5

—

5-aminosalicylic acid

2.27

1.03

3.0

2.9

—

Infections with a predominantly sexual mode of transmission

2.27

1.03

2.4

4.3

—

Congenital malformations of the circulatory system

110

1.59

1.03

5.9

2.1

—

Intracranial injury

110

1.58

1.02

2.5

2.6

—

1.66

1.01

2.9

2.2

—

Gingival hyperplasia

2.18

0.98

1.4

2.5

—

Melanocytic naevi

2.17

0.98

2.6

3.5

—

Other diseases of blood and blood-forming organs, wide

2.17

0.98

5.2

2.9

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Amino acids [Identifier] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS